BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32927086)

  • 1. Effects of syndecan-4 gene silencing by micro RNA interference in anoikis resistant endothelial cells: Syndecan-4 silencing and anoikis resistance.
    Onyeisi JOS; Pernambuco Filho PCA; Mesquita APS; Azevedo LC; Nader HB; Lopes CC
    Int J Biochem Cell Biol; 2020 Nov; 128():105848. PubMed ID: 32927086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of syndecan-4 silencing on the extracellular matrix remodeling in anoikis-resistant endothelial cells.
    Onyeisi JOS; Nader HB; Lopes CC
    Cell Biol Int; 2024 Jun; 48(6):883-897. PubMed ID: 38591778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of anoikis resistance up-regulates syndecan-4 expression in endothelial cells.
    Carneiro BR; Pernambuco Filho PC; Mesquita AP; da Silva DS; Pinhal MA; Nader HB; Lopes CC
    PLoS One; 2014; 9(12):e116001. PubMed ID: 25549223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase.
    Lopes CC; Toma L; Pinhal MA; Porcionatto MA; Sogayar MC; Dietrich CP; Nader HB
    Biochimie; 2006 Oct; 88(10):1493-504. PubMed ID: 16793191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate proteoglycans as trastuzumab targets in anoikis-resistant endothelial cells.
    Onyeisi JOS; Castanho de Almeida Pernambuco Filho P; de Araujo Lopes S; Nader HB; Lopes CC
    J Cell Biochem; 2019 Aug; 120(8):13826-13840. PubMed ID: 30945340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor α: a contributor to endothelial cell glycocalyx dysfunction.
    Ramnath R; Foster RR; Qiu Y; Cope G; Butler MJ; Salmon AH; Mathieson PW; Coward RJ; Welsh GI; Satchell SC
    FASEB J; 2014 Nov; 28(11):4686-99. PubMed ID: 25122554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan 4 supports bone fracture repair, but not fetal skeletal development, in mice.
    Bertrand J; Stange R; Hidding H; Echtermeyer F; Nalesso G; Godmann L; Timmen M; Bruckner P; Dell'Accio F; Raschke MJ; Pap T; Dreier R
    Arthritis Rheum; 2013 Mar; 65(3):743-52. PubMed ID: 23233348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-140-3p modulates invasiveness, motility, and extracellular matrix adhesion of breast cancer cells by targeting syndecan-4.
    Onyeisi JOS; Greve B; Espinoza-Sánchez NA; Kiesel L; Lopes CC; Götte M
    J Cell Biochem; 2021 Oct; 122(10):1491-1505. PubMed ID: 34180077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and roles of syndecan-4 in dental epithelial cell differentiation.
    Yan Z; Chen G; Yang Y; Sun L; Jiang Z; Feng L; Yu M; Guo W; Tian W
    Int J Mol Med; 2014 Nov; 34(5):1301-8. PubMed ID: 25174688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.
    Ridgway LD; Wetzel MD; Ngo JA; Erdreich-Epstein A; Marchetti D
    Mol Cancer Res; 2012 Jun; 10(6):689-702. PubMed ID: 22513363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.
    Scarpellini A; Huang L; Burhan I; Schroeder N; Funck M; Johnson TS; Verderio EA
    J Am Soc Nephrol; 2014 May; 25(5):1013-27. PubMed ID: 24357671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of syndecan-4 upregulation by TNF-α in the endothelium-like EAhy926 cells.
    Okuyama E; Suzuki A; Murata M; Ando Y; Kato I; Takagi Y; Takagi A; Murate T; Saito H; Kojima T
    J Biochem; 2013 Jul; 154(1):41-50. PubMed ID: 23576453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndecan-4 Modulates Epithelial Gut Barrier Function and Epithelial Regeneration in Experimental Colitis.
    Fröhling M; Tepasse P; Intemann J; Sambale M; Sherwood J; Paruzel P; Tiemeyer NM; Nowacki TM; Brückner M; Mennigen R; Lügering A; Echtermeyer F; Pap T; Stratis A; Bettenworth D
    Inflamm Bowel Dis; 2018 Nov; 24(12):2579-2589. PubMed ID: 30053064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells.
    de Sousa Mesquita AP; de Araújo Lopes S; Pernambuco Filho PCA; Nader HB; Lopes CC
    Apoptosis; 2017 Sep; 22(9):1116-1137. PubMed ID: 28653224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of syndecan-4 protein expression in colorectal cancer.
    Jechorek D; Haeusler-Pliske I; Meyer F; Roessner A
    Pathol Res Pract; 2021 Jun; 222():153431. PubMed ID: 34029877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycan, integrin, and syndecan-4 are mechanosensors mediating cyclic strain-modulated endothelial gene expression in mouse embryonic stem cell-derived endothelial cells.
    Nikmanesh M; Cancel LM; Shi ZD; Tarbell JM
    Biotechnol Bioeng; 2019 Oct; 116(10):2730-2741. PubMed ID: 31282995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-145 promoted anoikis resistance in tumor endothelial cells.
    Hida K; Kawamoto T; Maishi N; Morimoto M; Akiyama K; Ohga N; Shindoh M; Shinohara N; Hida Y
    J Biochem; 2017 Aug; 162(2):81-84. PubMed ID: 28510655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIF-1-PHD2 axis controls expression of syndecan 4 in nucleus pulposus cells.
    Fujita N; Hirose Y; Tran CM; Chiba K; Miyamoto T; Toyama Y; Shapiro IM; Risbud MV
    FASEB J; 2014 Jun; 28(6):2455-65. PubMed ID: 24558194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-4 in Tumor Cell Motility.
    Keller-Pinter A; Gyulai-Nagy S; Becsky D; Dux L; Rovo L
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival.
    Poças J; Marques C; Gomes C; Otake AH; Pinto F; Ferreira M; Silva T; Faria-Ramos I; Matos R; Ribeiro AR; Senra E; Cavadas B; Batista S; Maia J; Macedo JA; Lima L; Afonso LP; Ferreira JA; Santos LL; Polónia A; Osório H; Belting M; Reis CA; Costa-Silva B; Magalhães A
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2214853120. PubMed ID: 37155874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.